Non-invasive ocular surface analyser
Showing 9976 - 10000 of >10,000
Human Immunodeficiency Virus, Alcohol-Related Disorders, Drug Use Trial in Cape Town (Khanya)
Recruiting
- Human Immunodeficiency Virus
- +3 more
- Khanya
-
Cape Town, Western Cape, South AfricaUniversity of Cape Town
Jul 7, 2023
Fibromyalgia Trial in Potenza (Bedrocan®-type cannabis (22% THC, <1% CBD))
Completed
- Fibromyalgia
- Bedrocan®-type cannabis (22% THC, <1% CBD)
-
Potenza, ItalyPain Therapy Unit, San Carlo Hospital
Jun 30, 2023
Heart Failure Acute Trial in Heerlen (Urine sodium guided diuretic algorithm, Usual care)
Recruiting
- Heart Failure Acute
- Urine sodium guided diuretic algorithm
- Usual care
-
Heerlen, Limburg, NetherlandsZuyderland MC
Oct 17, 2023
Methotrexate and Azathioprine as Background Treatment for
Not yet recruiting
- Uveitis
-
Brest, FranceCHU de Brest
May 10, 2022
MRI Imaging of Retromuscular Hernia Repair With CICAT Visible®
Recruiting
- Hernia
- Recurrence
- Ventral hernia
-
Ghent, BelgiumAZ Maria Middelares
Jan 18, 2021
Uterine Bleeding Trial in Mansoura (Vaginal hysterectomy, Laparoscopic hysterectomy)
Completed
- Uterine Bleeding
- Vaginal hysterectomy
- Laparoscopic hysterectomy
-
Mansoura, Dakahlia, EgyptMansoura University Hospital
Sep 16, 2022
Patterns & Clinical Outcomes of Palbociclib Combinations in
Recruiting
- Metastatic Breast Cancer
-
Cairo, Egypt
- +7 more
Nov 8, 2022
Pulmonary Vein Stenosis Trial in Boston (Standardized catheterization assessment)
Recruiting
- Pulmonary Vein Stenosis
- Standardized catheterization assessment
-
Boston, MassachusettsBoston Children's Hospital
Jul 8, 2022
NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Phase I - Mirdametinib - Level 1
- +4 more
- (no location specified)
Jul 7, 2023
Outcomes of Retrocaecal Appendicitis With Non-retrocaecal
Completed
- Appendicitis
- +2 more
- Appendectomy
-
Praha 3, Prague, CzechiaAdam Whitley
Mar 30, 2022
Major Non-cardiac Surgeries Trial in Winnipeg, Ottawa (Tranexamic acid (TXA), Placebo (0.9 % Saline))
Recruiting
- Major Non-cardiac Surgeries
- Tranexamic acid (TXA)
- Placebo (0.9 % Saline)
-
Winnipeg, Manitoba, Canada
- +1 more
Apr 5, 2022
Metastatic Castrate-sensitive Prostate Cancer Trial in Germany, United States (Apalutamide, Androgen-deprivation Therapy (ADT))
Not yet recruiting
- Metastatic Castrate-sensitive Prostate Cancer
- Apalutamide
- Androgen-deprivation Therapy (ADT)
-
Lakewood, Colorado
- +5 more
May 23, 2023
Diabetic Foot Ulcer Trial in Hannover, Lódz (AUP1602-C)
Active, not recruiting
- Diabetic Foot Ulcer
- AUP1602-C
-
Hannover, Germany
- +1 more
Jun 7, 2022
Infant, Premature Trial in Istanbul (Replacement every 24 hours, Replacement every 12 hours)
Completed
- Infant, Premature
- Replacement every 24 hours
- Replacement every 12 hours
-
Istanbul, TurkeyAcıbadem University Atakent Hospital
Oct 21, 2021
Diaphragmatic Thickness and Functional Exercise Capacity in
Completed
- Video Assisted Thoracoscopic Surgery
- +2 more
-
Ankara, TurkeyHacettepe University
Dec 27, 2022
Rabies, Prevention Trial (PIKA-adjuvanted inactivated rabies vaccine, Rabipur)
Not yet recruiting
- Rabies
- Prevention
- PIKA-adjuvanted inactivated rabies vaccine
- Rabipur
- (no location specified)
Dec 28, 2022
NSCLC, Neoadjuvant Therapy Trial in Hangzhou (Serplulimab and neoadjuvant therapy, surgical resection of lung cancer)
Recruiting
- NSCLC
- Neoadjuvant Therapy
- Serplulimab and neoadjuvant therapy
- surgical resection of lung cancer
-
Hangzhou, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
May 22, 2023
Clinical Benefits Data of Anatomical Shoulder 2.0 Fracture
Recruiting
- Proximal Humerus Fracture
- +2 more
-
Firenze, Italy
- +1 more
Aug 1, 2022
NSITE Scoliosis Device Reproducibility Protocol
Recruiting
- Adolescent Idiopathic Scoliosis
- NSite 3D Scanning
-
Palo Alto, CaliforniaLucille Packard Children's Hospital and Clinics
Jan 14, 2023
B-cell Lymphoma, Non Hodgkin Lymphoma, DLBCL Trial in Louisville (Cyclophosphamide, Fludarabine, ACE1831)
Recruiting
- B-cell Lymphoma
- +5 more
- Cyclophosphamide
- +3 more
-
Louisville, KentuckyNorton Cancer Institute
Jan 24, 2023
Prostate Cancer, Recurrent Prostate Cancer Trial in Tampa (F-DCFPyL Injection, PSMA PET)
Recruiting
- Prostate Cancer
- Recurrent Prostate Cancer
- F-DCFPyL Injection
- PSMA PET
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023
Chronic Respiratory Failure Treated With Non-invasive Home
Recruiting
- Chronic Hypercapnic Respiratory Failure
- NIV cards
- Medical file
-
Nancy, FranceCHRU de Nancy - Site de Brabois
May 1, 2021